Who Qualifies for GLP-1 Treatment?

This is probably the biggest misconception.

GLP-1 medications originally became widely known because of their use in type 2 diabetes. But certain medications in this broader family are now specifically FDA approved for chronic weight management in qualifying patients.

So no — having diabetes isn't automatically required. FDA-approved chronic weight-management medications have eligibility criteria based primarily on BMI and weight-related health conditions, not simply whether someone has diabetes.

For adults, FDA-approved medications for chronic weight management such as Wegovy and Zepbound have generally been indicated for people with:

• BMI of 30 or higher, or
• BMI of 27 or higher plus at least one weight-related medical condition

That second category is important.

Someone doesn't necessarily need to have obesity by BMI classification to potentially meet the approved weight-management indication. Being overweight plus an associated health condition may be enough.

Examples can include conditions such as:

• High blood pressure
• High cholesterol or abnormal blood lipids
• Type 2 diabetes
• Obstructive sleep apnea
• Cardiovascular disease

— depending on the medication's specific indication and the patient's medical situation.

So imagine two people.

That's why looking at the entire health picture matters.

BMI stands for Body Mass Index. It's a simple calculation using your height and weight.

BMI is useful because it gives healthcare providers a standardized starting point. But it isn't a perfect measurement of health. It doesn't directly measure:

• Body-fat percentage
• Muscle mass
• Where you carry body fat
• Metabolic health
• Fitness
• Your entire medical history

A muscular person and a sedentary person could theoretically have the exact same BMI while having very different body compositions.

BMI is a screening tool — not your entire health story.

Possibly.

How many pounds you want to lose isn't the only factor. Someone might want to lose 25 pounds and have a BMI above 30. Another person could want to lose 40 pounds but have different medical considerations that make a particular medication inappropriate.

A healthcare provider may look at:

• Current weight
• Height and BMI
• Weight history
• Previous weight-loss attempts
• Medical conditions
• Current medications
• Family and personal medical history
• Treatment goals
• Potential medication risks

That's why qualification isn't simply “How much weight do you want to lose?”

This is where people need to be careful.

GLP-1 medications aren't intended to be casual cosmetic weight-loss products. Someone at a healthy weight who simply wants to lose a few pounds before vacation shouldn't assume a GLP-1 is appropriate.

For FDA-approved chronic weight-management indications, the usual adult thresholds begin at BMI ≥30, or BMI ≥27 with an applicable weight-related condition.

If you fall outside the approved indication, the conversation becomes more individualized and depends on the medication, intended use, clinical circumstances, and prescriber's judgment.

No. This gets confused constantly.

There are really two separate questions:

• Medical eligibility — does a healthcare provider believe the medication is appropriate for you?
• Insurance coverage — will your insurance company pay for that particular medication?

Those aren't the same thing.

You could be an appropriate candidate for treatment and still have an insurance plan that:

• Doesn't cover weight-loss medications
• Requires prior authorization
• Requires documentation of previous treatments
• Has its own BMI requirements
• Excludes obesity medications entirely

Likewise, insurance coverage doesn't replace a medical evaluation. Your insurance company determines coverage. Your healthcare provider determines whether treatment is appropriate.

Your BMI may get you through the first door. Your health history determines what happens next.

Your weight history. Have you struggled with weight for years? Has your weight repeatedly gone down and returned? Have lifestyle changes produced limited results?

Your medical history. Conditions affecting your gastrointestinal system, pancreas, gallbladder, kidneys, endocrine system, and other areas can matter.

Your medications. Certain medications or combinations may affect whether a particular GLP-1 treatment is appropriate.

Your family history. Some GLP-1 medications carry boxed warnings involving thyroid C-cell tumors based on animal findings and are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). That's why seemingly random questions on your intake form actually matter.

Pregnancy. GLP-1-based weight-management medications aren't appropriate for weight loss during pregnancy. Pregnancy plans can also affect treatment decisions, because some medications need to be discontinued before a planned pregnancy.

Qualification isn't only about checking boxes that say yes.

Sometimes the most important part of an evaluation is identifying reasons treatment might not be appropriate. Depending on the specific medication, examples can include:

• Pregnancy
• Certain personal or family thyroid-cancer histories
• MEN 2
• Certain medication interactions or overlapping treatments
• Specific gastrointestinal or other medical conditions requiring additional evaluation
• Previous serious reactions to the medication or its ingredients

And some situations aren't automatic “no's” — they simply require a closer clinical review. That's why an intake should be reviewed by a licensed healthcare provider rather than automatically approving everyone who enters a qualifying BMI.

This is where medical weight management can change the conversation.

Many people considering GLP-1 treatment have already tried:

• Calorie tracking
• Low-carb diets
• Intermittent fasting
• Gym memberships
• Meal plans
• Personal trainers
• Weight-loss apps

Sometimes repeatedly.

That doesn't mean nutrition and exercise suddenly stop mattering. They still do. But obesity is a chronic disease influenced by much more than willpower alone. Appetite signaling, genetics, environment, sleep, medications, metabolic health, and other factors can all influence weight.

For an appropriate patient, medication can become another tool in the overall treatment plan. You don't have to “fail harder” before asking whether medical treatment makes sense.

You don't have to.

The word obesity is a medical classification, not a description of someone's appearance. Someone with a BMI of 30 may look completely different from another person with the same BMI. Height, muscle mass, body composition, fat distribution, age, and genetics all influence appearance.

That's why eligibility shouldn't be determined by someone looking at you and deciding whether you “look big enough.” Healthcare decisions should be based on health information — not stereotypes.

Potentially, yes.

This is worth emphasizing because many people assume GLP-1 weight-management treatment begins only after BMI reaches 30.

For certain FDA-approved weight-management medications, adults with BMI 27 or greater may meet the indication when they also have at least one qualifying weight-related condition. Examples can include:

• High blood pressure
• Abnormal cholesterol
• Type 2 diabetes
• Sleep apnea
• Certain other weight-related conditions depending on the medication

So overweight doesn't automatically mean “not eligible.” Your overall health matters.

They may still meet the BMI component of an FDA-approved chronic weight-management indication. That's because the general framework is BMI 30+, or BMI 27+ with a weight-related condition. You don't necessarily need both.

Of course, meeting the BMI threshold doesn't guarantee a prescription. A provider still needs to determine that the medication is appropriate based on your individual medical history.

Here's an easy way to think about the process:

Notice what's missing: “Pick whichever medication you want and buy it.” GLP-1 treatment is prescription medical care.

Not necessarily.

There are multiple medications used in metabolic and weight-management care. Even when someone is an appropriate candidate for pharmacologic treatment, the provider still has to determine which treatment makes sense. Factors can include:

• Medical history
• Previous treatment
• Side-effect considerations
• Treatment goals
• Medication availability
• Approved indications
• Cost and coverage
• Patient preferences

That's why two patients with identical BMIs could receive different treatment recommendations. The goal isn't to qualify for a specific drug — the goal is to find an appropriate treatment plan.

This deserves its own distinction.

The BMI criteria above describe FDA-approved chronic weight-management indications for specific commercial medications. Compounded medications are not FDA approved, and their prescribing and compounding must comply with applicable federal and state requirements.

A compounded GLP-1 shouldn't simply be treated as an automatically interchangeable, cheaper version of an FDA-approved medication.

When compounded treatment is considered, the healthcare provider still needs to determine whether it is medically appropriate for the individual patient and whether the circumstances meet applicable compounding requirements.

If you're wondering whether it's worth completing an evaluation, start here. You may be worth evaluating for GLP-1 weight-management treatment if:

• Your BMI is 30 or greater, or your BMI is at least 27 and you have a weight-related medical condition
• You're interested in medically supervised long-term weight management
• A licensed healthcare provider determines treatment is appropriate based on your health history

You don't necessarily need diabetes. You don't necessarily need to be 100 pounds overweight. And you don't need to wait until weight-related health problems become dramatically worse before having a conversation with a healthcare provider.

For certain FDA-approved GLP-1-based weight-management medications, adults generally meet the weight portion of the indication with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition.

But BMI is only the starting point. Your medical history, medications, health conditions, treatment goals, contraindications, and individual risk profile all matter.

The real question isn't simply, “Do I qualify?” It's: “Is GLP-1 treatment appropriate for me?” And that's exactly what a medical evaluation is designed to determine.